|
⚲
|
| Keyboard |
| Prince Joshua S
✚
|
|
|---|---|
| CIK # | 0001998663 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001998663] | |
| 4 | [0001998663] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vistagen Therapeutics Inc | |
| Prince Joshua S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2025-12-31 | Grant | 4,386 | $0.56 | 2,456 |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2025-06-30 | Grant | 4,882 | $1.70 | 8,299 |
|
Vistagen Therapeutics Inc VTGN
Stock Option (Right to Buy) · derivative
|
2025-06-23 | Grant | 100,000 | $0.00 | |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2024-12-31 | Grant | 3,310 | $2.51 | 8,308 |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2024-06-28 | Grant | 2,671 | $2.96 | 7,906 |
|
Vistagen Therapeutics Inc VTGN
Stock Option (Right to Buy) · derivative
|
2024-06-24 | Grant | 150,000 | $0.00 |